Quercetin inhibiting the PD ‐1/ PD‐L1 interaction for immune‐enhancing cancer chemopreventive agent
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quercetin inhibiting the
PD
‐1/
PD‐L1
interaction for immune‐enhancing cancer chemopreventive agent
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume 35, Issue 11, Pages 6441-6451
Publisher
Wiley
Online
2021-09-25
DOI
10.1002/ptr.7297
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer
- (2020) James Randall Patrinely et al. BIODRUGS
- Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate/d-α-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles
- (2020) Shuo Liu et al. MOLECULAR PHARMACEUTICS
- PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
- (2020) Jian-ye Zhang et al. Frontiers in Pharmacology
- Quercetin inhibits TNF-α induced HUVECs apoptosis and inflammation via downregulating NF-kB and AP-1 signaling pathway in vitro
- (2020) Tielong Chen et al. MEDICINE
- Quercetin modulates signaling pathways and induces apoptosis in cervical cancer cells
- (2019) Madhumitha Kedhari Sundaram et al. BIOSCIENCE REPORTS
- The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
- (2019) Luca Mazzarella et al. EUROPEAN JOURNAL OF CANCER
- Progress in PD-1/PD-L1 pathway inhibitors: From biomacromolecules to small molecules
- (2019) Xin Lin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Antitumor and apoptotic effects of quercetin on human melanoma cells involving JNK/P38 MAPK signaling activation
- (2019) Sung-Hyun Kim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Immune Checkpoint PD-1/PD-L1 CTLA-4/CD80 are Blocked by Rhus verniciflua Stokes and its Active Compounds
- (2019) Wei Li et al. MOLECULES
- Retreatment with anti‐PD‐1 antibody in non‐small cell lung cancer patients previously treated with anti‐PD‐L1 antibody
- (2019) Kohei Fujita et al. Thoracic Cancer
- Quercetin and Quercitrin Attenuates the Inflammatory Response and Oxidative Stress in LPS-Induced RAW264.7 Cells: In Vitro Assessment and a Theoretical Model
- (2019) Jie Tang et al. Biomed Research International
- Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects
- (2019) Si-Min Tang et al. BIOMEDICINE & PHARMACOTHERAPY
- Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling
- (2018) Shin-ichi Tsukumo et al. Frontiers in Immunology
- A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018)
- (2018) Shabnam Shaabani et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of PI3K/Akt signaling
- (2016) Xinsheng Shen et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Quercetin and Its Anti-Allergic Immune Response
- (2016) Jiri Mlcek et al. MOLECULES
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
- (2016) Chia-Wei Li et al. Nature Communications
- Quercetin, Inflammation and Immunity
- (2016) Yao Li et al. Nutrients
- BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
- (2016) Hengrui Zhu et al. Cell Reports
- PD-1/PD-L1 inhibitors
- (2015) Joel Sunshine et al. CURRENT OPINION IN PHARMACOLOGY
- A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19+tumor cells
- (2015) Uwe Reusch et al. mAbs
- Effect of different exposed lights on quercetin and quercetin glucoside content in onion (Allium cepa L.)
- (2015) Eun Young Ko et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth
- (2015) Feiya Yang et al. PLoS One
- A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy
- (2015) Shintaro Taki et al. PLoS One
- Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats
- (2013) S.S. Karuppagounder et al. NEUROSCIENCE
- The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo
- (2011) A. M. Paterson et al. JOURNAL OF IMMUNOLOGY
- Combination of quercetin with radiotherapy enhances tumor radiosensitivity in vitro and in vivo
- (2011) Chenghe Lin et al. RADIOTHERAPY AND ONCOLOGY
- Protective Effect of Quercetin against Arsenite-Induced COX-2 Expression by Targeting PI3K in Rat Liver Epithelial Cells
- (2010) Kyung Mi Lee et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Quercetin Enhances Susceptibility to NK Cell-mediated Lysis of Tumor Cells Through Induction of NKG2D Ligands and Suppression of HSP70
- (2010) Jae-Ho Bae et al. JOURNAL OF IMMUNOTHERAPY
- Quercetin regulates Th1/Th2 balance in a murine model of asthma
- (2008) Hee-ju Park et al. INTERNATIONAL IMMUNOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started